PSNL
Personalis IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$886.99M
P/E Ratio
—
EPS
$-1.02
Beta
1.97
52W High
$11.50
52W Low
$3.84
50-Day MA
$6.53
200-Day MA
$7.55
Dividend Yield
—
Profit Margin
-148.10%
Forward P/E
—
PEG Ratio
—
About Personalis Inc
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $64.52M |
| Gross Profit (TTM) | $8.85M |
| EBITDA | $-92.69M |
| Operating Margin | -207.90% |
| Return on Equity | -41.40% |
| Return on Assets | -21.40% |
| Revenue/Share (TTM) | $0.69 |
| Book Value | $2.43 |
| Price-to-Book | 3.48 |
| Price-to-Sales (TTM) | 13.75 |
| EV/Revenue | 10.73 |
| EV/EBITDA | -0.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -24.90% |
| Shares Outstanding | $104.72M |
| Float | $62.48M |
| % Insiders | 27.05% |
| % Institutions | 70.13% |
Historical Volatility
HV 10-Day
77.49%
HV 20-Day
92.86%
HV 30-Day
84.27%
HV 60-Day
86.55%
HV Rank
40.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($10.86 target)
1
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026